本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AEON Biopharma

0.8376
-0.0024-0.29%
盘后0.8364-0.0012-0.14%16:55 EDT
成交量:23.48万
成交额:20.22万
市值:946.94万
市盈率:0.01
高:0.9074
开:0.8400
低:0.8301
收:0.8400
数据加载中...
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/24

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/10/23

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/19

重要事件披露

Form 8-K - Current report
2023/10/03

重要事件披露

Form 8-K - Current report
2023/08/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/19

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/08/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/08/01

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/07/28

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/07/27

重要事件披露

Form 8-K - Current report
2023/07/24

重要事件披露

Form 8-K - Current report
2023/07/21

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/21

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2023/07/20

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/17

重要事件披露

Form 8-K - Current report
2023/07/17

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/07/12

重要事件披露

Form 8-K - Current report